General Information of the Compound
| Compound ID |
CP0372352
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3,3-diphenylpropyl)-2,2-diphenylacetamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
AC1N5W5U
AKOS003236993
BDBM50263033
CHEMBL476529
MCULE-9181870252
N-(3,3-Diphenyl)propyl-2,2-diphenylacetamide
N-(3,3-diphenylpropyl)-2,2-diphenylacetamide
Oprea1_456266
SR-01000512723
ST45008037
ZINC3166084
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H27NO
|
||||||||||||||||||
| Molecular Weight |
405.541
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCCC(c1ccccc1)c1ccccc1)C(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H27NO/c31-29(28(25-17-9-3-10-18-25)26-19-11-4-12-20-26)30-22-21-27(23-13-5-1-6-14-23)24-15-7-2-8-16-24/h1-20,27-28H,21-22H2,(H,30,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LMRDWMVRJNJYIQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2
Clinical Information about the Compound